Medicaid

Medicaid MSP Enrollment Streamlined: Key Billing Updates Effective November 17

Source published September 21, 2023

What Changed The Medicare Savings Programs (MSPs) payment system has undergone a significant update with the Federal Register Final Rule (Policy ID: FR-2023-20382), effective November 17, 2023. This u

Action required by

November 17, 2023

Review the Action Required section below and ensure your team has completed all compliance steps before this date.

What Changed The Medicare Savings Programs (MSPs) payment system has undergone a significant update with the Federal Register Final Rule (Policy ID: FR-2023-20382), effective November 17, 2023. This update streamlines the enrollment and eligibility determination processes, reducing the documentation burden for applicants and allowing for automatic enrollment in certain cases. This change is expected to enhance access to benefits for eligible individuals by simplifying the administrative hurdles traditionally associated with MSP enrollment.

Why It Matters for Coding While the specific CPT, HCPCS, or ICD-10 codes directly affected by this rule have not been detailed, the changes will impact claims submission and documentation processes. Coders and billing professionals should be aware that the streamlined processes may alter how income and resource verification is documented, potentially affecting the selection of codes related to eligibility and enrollment. Understanding these changes is crucial for ensuring that claims are submitted accurately and that the appropriate documentation supports the eligibility of individuals enrolled in MSPs. As the focus is on administrative processes, coders should remain vigilant for any subsequent updates that may affect specific code types.

Sign in to read the full article

Create a free account to access the complete analysis, action recommendations, and related alert references.

Content summarized from publicly available federal publications including CMS, MAC contractors, and the Federal Register. CLV Intelligence is not affiliated with or endorsed by any government agency. This is not legal or medical advice.